Table 2.
Comparison of ACCI with score weights between survivors and non-survivors of SFTS
| Comorbidity | Score | Total (n = 192) | Survivors (n = 141) | Non-survivors (n = 51) | p value |
|---|---|---|---|---|---|
| Myocardial infarction | 1 | 2 (1.0%) | 0 (0.0%) | 2 (3.9%) | 0.070 |
| Chronic cardiac failure | 1 | 2 (1.0%) | 0 (0.0%) | 2 (3.9%) | 0.070 |
| Peripheral vascular disease | 1 | 6 (3.1%) | 1 (0.7%) | 5 (9.8%) | 0.005 |
| Cerebrovascular disease | 1 | 22 (11.5%) | 6 (4.3%) | 16 (31.4%) | <0.001 |
| Dementia | 1 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
| Chronic pulmonary disease | 1 | 2 (1.0%) | 1 (0.7%) | 1 (2.0%) | 0.046 |
| Connective tissue disease | 1 | 3 (1.6%) | 1 (0.7%) | 2 (3.9%) | 0.173 |
| Peptic ulcer | 1 | 5 (2.6%) | 4 (2.8%) | 1 (2.0%) | 1.000 |
| Mild liver disease | 1 | 10 (5.2%) | 7 (5.0%) | 3 (5.9%) | 1.000 |
| Diabetes mellitus | 1 | 44 (22.9%) | 28 (19.9%) | 16 (31.4%) | 0.119 |
| Hemiplegia | 2 | 1 (0.5%) | 0 (0.0%) | 1 (2.0%) | 0.266 |
| Diabetes with end-organ damage | 2 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
| Moderate/severe renal disease | 2 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
| Tumour/Leukaemia/Lymphoma | 2 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
| Moderate/severe liver disease | 2 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
| Metastatic solid tumour/AIDS | 6 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
| Age | <0.001 | ||||
| <50 years | 0 | 28 (14.6%) | 27 (19.1%) | 1 (2.0%) | |
| 50–59 years | 1 | 41 (21.4%) | 38 (27.0%) | 3 (5.9%) | |
| 60–69 years | 2 | 69 (35.9%) | 52 (36.9%) | 17 (33.3%) | |
| 70–79 years | 3 | 49 (25.5%) | 24 (17.0%) | 25 (49.0%) | |
| ≥80 years | 4 | 5 (2.6%) | 0 (0.0%) | 5 (9.8%) |
Abbreviations: ACCI, age-adjusted Charlson Comorbidity Index; AIDS, acquired immune deficiency syndrome.